Mestanolone

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mestanolone

Clinical data
Pregnancy category	US: X (Contraindicated)
Routes of administration	Oral
Legal status
Legal status	DEA Schedule III (US)
Pharmacokinetic data
Bioavailability	99% oral
Protein binding	yes
Metabolism	Hepatic
Elimination half-life	?
Excretion	Renal
Identifiers
IUPAC name (5S,8R,9S,10S,13S,14S,17S) -17-hydroxy-10,13,17-trimethyl-2,4,5,6,7,8,9,11,12,14,15, 16-dodecahydro-1H-cyclopenta[a]phenanthren-3-one
CAS Number	521-11-9
PubChem CID	10633
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C20H32O2
Molar mass	304.467 g/mol

WikiDoc Resources for Mestanolone
Articles
Most recent articles on Mestanolone Most cited articles on Mestanolone Review articles on Mestanolone Articles on Mestanolone in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mestanolone Images of Mestanolone Photos of Mestanolone Podcasts & MP3s on Mestanolone Videos on Mestanolone
Evidence Based Medicine
Cochrane Collaboration on Mestanolone Bandolier on Mestanolone TRIP on Mestanolone
Clinical Trials
Ongoing Trials on Mestanolone at Clinical Trials.gov Trial results on Mestanolone Clinical Trials on Mestanolone at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mestanolone NICE Guidance on Mestanolone NHS PRODIGY Guidance FDA on Mestanolone CDC on Mestanolone
Books
Books on Mestanolone
News
Mestanolone in the news Be alerted to news on Mestanolone News trends on Mestanolone
Commentary
Blogs on Mestanolone
Definitions
Definitions of Mestanolone
Patient Resources / Community
Patient resources on Mestanolone Discussion groups on Mestanolone Patient Handouts on Mestanolone Directions to Hospitals Treating Mestanolone Risk calculators and risk factors for Mestanolone
Healthcare Provider Resources
Symptoms of Mestanolone Causes & Risk Factors for Mestanolone Diagnostic studies for Mestanolone Treatment of Mestanolone
Continuing Medical Education (CME)
CME Programs on Mestanolone
International
Mestanolone en Espanol Mestanolone en Francais
Business
Mestanolone in the Marketplace Patents on Mestanolone
Experimental / Informatics
List of terms related to Mestanolone

Mestanolone is the 17α-methylated version of dihydrotestosterone (DHT). The systematic name of mestanolone is: 17β-hydroxy-17α-methylandrost-3-one. It is an orally bioavailable androgenic steroid that is highly androgenic while only slightly anabolic. It is incapable of aromatization and is not an agonist of the progesterone receptor.

References

Template:WikiDoc Sources